OBJECTIVE: To summarize clinical outcomes and adverse effects of medical abortion
regimens consisting of mifepristone followed by buccal misoprostol in pregnancies through …

Importance Screening for medication abortion eligibility typically includes ultrasonography
or pelvic examination. To reduce physical contact during the COVID-19 pandemic, many …

Objectives To assess self reported outcomes and adverse events after self sourced medical
abortion through online telemedicine. Design Population based study. Setting Republic of …

Objective This guideline reviews the evidence relating to the provision of first-trimester
medical induced abortion, including patient eligibility, counselling, and consent; evidence …

Background Telemedicine for medical abortion increases access to safe abortion but its use
has not been described in a controlled trial. We aimed to investigate the effectiveness …

Objective To describe how a general-practitioner-delivered community medical abortion
service is provided in Ireland, including a description of the unique model of care delivered …

OBJECTIVE: To compare efficacy between medical and surgical abortion at 9 weeks of
gestation or less. METHODS: We performed a retrospective cohort study comparing efficacy …

Background In 2014, a composite pack containing mifepristone‐buccal misoprostol,
indicated for use to 63 days gestation replaced the existing regimen for early medical …

Objectives This open-label non-inferiority study assessed efficacy of a common outpatient
medical abortion regimen among people with pregnancies 64–70 days and 71–77 days of …

Background: Medical abortion (using mifepristone followed by misoprostol to end an early
pregnancy) is a more accessible and less invasive option than surgical termination and can …